Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A-MedSci.cn

Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A

Mazieres, J; Paik, PK; Felip, E; Veillon, R; Sakai, H; Cortot, AB; Viteri, S; Garassino, MC; Van Meerbeeck, JP; Raskin, J; Thomas, M; Morise, M; Cho, BC; Conte, P; Bruns, R; Demuth, T; Schumacher, KM; Le, X

ANNALS OF ONCOLOGY, 2020; 31 (): S828

科室
- - 订阅+
  - 更多科室
工具
服务